Humira (adalimumab) - AbbVie
Amjevita (adalimumab-atto) - Amgen, Daiichi Sankyo
Cyltezo (adalimumab-adbm) - Boehringer Ingelheim
Yuflyma (adalimumab-aaty) - Celltrion, Hikma
Three biosimilars have now landed in our @SSMIBDCare New learning ✨ New experience ✨ Humira-adalimumab Amjevita- adalimumab-atto Cyltezo- adalimumab- adbm Yuflyma- adalimumab-aaty Sep 21, 2023 
https://twitter.com/ibdtweets/status/1704650613374480642
 
Sep 21, 2023
 
 
b4663fc9-a79e-40cd-9d85-89b16a1e2187.jpg